Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
October 13th, 2025
Clinical Trial Progress: Imugene Data Continues to Impress
Read More
October 12th, 2025
Positive Outcome for Dimerix from PARASOLProject Sets Up FDA Meeting
Read More
October 11th, 2025
Amplia Achieves Additional Partial Response as Data Begins to Mature
Read More
October 10th, 2025
Chimeric Therapeutics - More EncouragingData from Phase I Studies
Read More
September 26th, 2025
Clinuvel Pharmaceuticals Gains Extended Use of Scenesse in Europe
Read More
September 26th, 2025
Botanix Pharmaceuticals - Profitability in Sight?
Read More
September 26th, 2025
Chimeric Therapeutics - More Data Emerging from Phase I CAR-T Study
Read More
September 12th, 2025
Aroa Biosurgery — Records Third Positive Cashflow Quarter
Read More
September 11th, 2025
Clinuvel Grows Cash Balance to $224M and Progresses Phase III Vitiligo Program
Read More
August 26th, 2025
Actinogen Medical — Why Xanamem Should Deliver Positive Results in Phase IIb Alzheimer’s Disease Study
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
